'Zealand Pharma Makes Deal With Generate Worth Up to $1.2 Billion' - Bloomberg

Zealand Pharma has entered into a deal with Generate Biomedicines valued at up to $1.2 billion. This agreement is expected to enhance Zealand's pipeline and expand its therapeutic offerings. The collaboration will involve milestone payments and royalties based on future sales, indicating a significant strategic move for both companies.